AVXL
Anavex Life SciencesFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
AVXL vs peer average
20/100
AVXL vs. peer average (F vs. C)
Grade spread
A 2 · B 1 · C 1 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
AKBA is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $273.62M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AVXL
Anavex Life Sciences
AKBA
Akebia Therapeutics
Grade
F
D
Momentum
4
16
Value
41
66
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs AKBA
AVXL / AKBA
Grade Position
Below peers
AVXL vs. peer average (F vs. C)
20/100
Momentum
4
AKBAValue
41
AKBASentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AVXL
AKBA is the first peer returned for this comparison set.

